YOUTUBE WEBINAR ON: DRUG TESTING, PHYSICALS AND COMPLIANCE  DURING COVID-19 LEARN FROM THE EXPERTS. 

Speakers :

Margaret Spence, CEO of C. Douglas & Asociates, Inc.

Patrick Armstrong, VP of O.M. Management, Inc.

Johanna Penafiel, National Account Manager, O.M. Management, Inc.

Maxine Topper,  Executive VP, Physicians Health Center.

Business owners and companies strive to promote a safe working environment for all employees, where better health is encouraged. Therefore, most of the organizations consider the usage of alcohol and drugs on the job as a counterproductive and unsafe practice and aim to maintain a drug free workplace.

“The FMCSA Clearinghouse is a centralized database that employers will use to report drug and alcohol program violations and to check that current or prospective employees are not prohibited from performing safety-sensitive functions, such as operating a commercial motor vehicle (CMV), due to an unresolved drug and alcohol program violation—that is, a violation for which the driver has not completed the return-to-duty (RTD) process. This query must be conducted as part of a pre-employment driver investigation, and at least annually for current employees.” – FMCSA Clearinghouse.

DOT regulations mandates the use of the Clearinghouse to go into effect January 6th, 2020. Employers, independent drivers/owner-operators, and Medical Review Officers will be required to report all positive DOT tests for drugs and/or alcohol, including refusals to comply with drug and alcohol testing. Employers and drivers will need to fill out authorization forms and